Benzinga | Apr 5, 2021 07:39AM EDT

Invitae Announces $1.15B Investment In Its Convertible Senior Notes By Softbank Subsidiary

Invitae (NYSE:NVTA), a leading medical genetics company, today announced that a small group of investors, led by SB Management, a subsidiary of Softbank Group Corp., will make an investment of $1.15 billion in convertible senior notes to support the Company's future growth initiatives.